Researchers ← FRAXA Blog

CTEP now available! Attention all neuroscientists!

Feb

2013

I get a lot of inquiries from scientists asking about the availability of CTEP, the latest and greatest mGluR5 antagonist. It’s much more potent and much longer acting than MPEP or fenobam, and is comparable to Roche’s lead mGluR5 antagonist currently in clinical trials for fragile X—not surprising, since CTEP was developed by Roche scientists. ...

Gordon Research Conference on Fragile X register until May 13

Apr

2012

Gordon Conference in Fragile X and Autism-related Disorders June 10-15, 2012, in Easton, MA This is the first ever Gordon Research Conference on Fragile X, so it should be quite exciting. Registration closes soon so it’s a good time to make plans to attend the meeting. The preliminary program is posted at http://www.grc.org/programs.aspx?year=2012&program=fragilex

Grants of $1 million from John Merck Fund

Feb

2012

The new John Merck Fund Developmental Disabilities Translational Research Program will support researchers in developing treatments for Down syndrome and Fragile X syndrome (and FX associated disorders). Over the next ten years, the Translational Research Program will make approximately ten awards of $1 million each ($250,000 per year for four years). The awards will be ...

FRAXA Blog in progress!

Feb

2012

We’ve just started this new blog and hope to bring you lots of updates soon.